ASKLEPION PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, July 18, 2007, a trademark application was filed for ASKLEPION PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ASKLEPION PHARMACEUTICALS trademark a serial number of 77232242. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, October 29, 2018. This trademark is owned by Asklepion Pharmaceuticals, LLC. The ASKLEPION PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical research and development
asklepion pharmaceuticals

General Information

Serial Number77232242
Word MarkASKLEPION PHARMACEUTICALS
Filing DateWednesday, July 18, 2007
Status800 - REGISTERED AND RENEWED
Status DateMonday, October 29, 2018
Registration Number3525208
Registration DateTuesday, October 28, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2007

Trademark Statements

Certificate of Correction for RegistrationIn the statement, column 1, lines 1 and 2, "TENNESSEE" should be deleted, and "DELAWARE" should be inserted.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and Servicespharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 23, 2007
Primary Code042
First Use Anywhere DateSaturday, April 1, 2006
First Use In Commerce DateSaturday, April 1, 2006

Trademark Owner History

Party NameAsklepion Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21202
Party NameAsklepion Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBrentwood, TN 37027
Party NameAsklepion Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBrentwood, TN 37027

Trademark Events

Event DateEvent Description
Tuesday, March 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 29, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, October 29, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, October 29, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, October 29, 2018CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, October 29, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, October 27, 2018POST REGISTRATION ACTION MAILED - SEC. 7
Thursday, October 25, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, October 24, 2018POST REGISTRATION ACTION MAILED - SEC. 7
Wednesday, October 17, 2018TEAS SECTION 7 REQUEST RECEIVED
Wednesday, October 17, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, December 21, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 30, 2017POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, November 30, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 2, 2017TEAS SECTION 8 & 9 RECEIVED
Saturday, October 28, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 5, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, November 5, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 3, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 23, 2014TEAS SECTION 8 & 15 RECEIVED
Thursday, October 23, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 17, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 28, 2008REGISTERED-PRINCIPAL REGISTER
Wednesday, September 24, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, September 24, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 22, 2008STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 18, 2008USE AMENDMENT FILED
Monday, September 22, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 18, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, March 18, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 25, 2007PUBLISHED FOR OPPOSITION
Thursday, December 6, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 5, 2007NOTICE OF PUBLICATION
Friday, November 30, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 16, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 16, 2007ASSIGNED TO LIE
Monday, October 15, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 15, 2007EXAMINER'S AMENDMENT ENTERED
Monday, October 15, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 15, 2007EXAMINERS AMENDMENT E-MAILED
Monday, October 15, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 3, 2007ASSIGNED TO EXAMINER
Monday, July 23, 2007NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals asklepion development research pharmaceutical